TY - JOUR
T1 - Association between self-medication with antibiotics and purchase of brand-name drugs
T2 - Analysis of a national survey in Peru
AU - Benites-Meza, Jerry K.
AU - Herrera-Añazco, Percy
AU - Santillán-Rodríguez, Arón A.
AU - Zumarán-Nuñez, Carlos J.
AU - Barturén-Alvarado, Luz C.
AU - Benites Zapata, Vicente A.
N1 - Publisher Copyright:
© 2023 The Author(s). Published by Oxford University Press on behalf of the Royal Pharmaceutical Society. All rights reserved.
PY - 2023/4/24
Y1 - 2023/4/24
N2 - Objectives: To determine the association between self-medication with antibiotics (SMA) and purchase of brand-name drugs in Peru. Methods: A secondary analysis was conducted using a nationally representative survey from 2014 to 2016. The exposure variable was self-medication (SM), which is defined as the purchase of drugs for self-administration without a medical prescription. The study outcome was the purchase of brand-name drugs (yes/no). Sociodemographic variables, such as health insurance and type of institution, were considered as confounders. To assess the association between SMA and the purchase of brand-name drugs, the crude prevalence ratios (cPR) and adjusted prevalence ratios (aPR) were calculated with their confidence intervals at 95% (95% CI) using a Poisson-type generalized linear model and considering the complex survey design. Key findings: A total of 1862 participants were analysed; 54.4% of the participants were women with a mean age of 39.3 years. The prevalence rate of SMA was 54.3%, whereas that of the purchase of brand-name drugs was 55.3%. The adjusted Poisson regression analysis showed an association between SMA and the purchase of brand-name drugs (aPR = 1.28; 95% CI: 1.18-1.37; P < 0.001). Conclusions: It was found that 5 of 10 respondents SMA. Approximately 6 of 10 respondents that SMA used brand-name drugs. SMA is associated with a higher probability of purchasing brand-name drugs.
AB - Objectives: To determine the association between self-medication with antibiotics (SMA) and purchase of brand-name drugs in Peru. Methods: A secondary analysis was conducted using a nationally representative survey from 2014 to 2016. The exposure variable was self-medication (SM), which is defined as the purchase of drugs for self-administration without a medical prescription. The study outcome was the purchase of brand-name drugs (yes/no). Sociodemographic variables, such as health insurance and type of institution, were considered as confounders. To assess the association between SMA and the purchase of brand-name drugs, the crude prevalence ratios (cPR) and adjusted prevalence ratios (aPR) were calculated with their confidence intervals at 95% (95% CI) using a Poisson-type generalized linear model and considering the complex survey design. Key findings: A total of 1862 participants were analysed; 54.4% of the participants were women with a mean age of 39.3 years. The prevalence rate of SMA was 54.3%, whereas that of the purchase of brand-name drugs was 55.3%. The adjusted Poisson regression analysis showed an association between SMA and the purchase of brand-name drugs (aPR = 1.28; 95% CI: 1.18-1.37; P < 0.001). Conclusions: It was found that 5 of 10 respondents SMA. Approximately 6 of 10 respondents that SMA used brand-name drugs. SMA is associated with a higher probability of purchasing brand-name drugs.
KW - Peru
KW - antibiotics
KW - drugs
KW - self-medication
UR - http://www.scopus.com/inward/record.url?scp=85163732973&partnerID=8YFLogxK
U2 - 10.1093/jphsr/rmad015
DO - 10.1093/jphsr/rmad015
M3 - Artículo
AN - SCOPUS:85163732973
SN - 1759-8885
VL - 14
SP - 112
EP - 122
JO - Journal of Pharmaceutical Health Services Research
JF - Journal of Pharmaceutical Health Services Research
IS - 2
ER -